CN Patent

CN111773226A — 噻吗洛尔或其盐在制备预防和/或治疗丛状血管瘤的药物中的用途

Assigned to Beijing Childrens Hospital · Expires 2020-10-16 · 6y expired

What this patent protects

本发明涉及噻吗洛尔或其盐在制备预防和/或治疗丛状血管瘤的药物中的用途。本发明的噻吗洛尔或其盐治疗丛状血管瘤采用局部涂覆方式使用，没有任何创伤，使用简单，治疗耐受性良好，治愈率极高，愈后未见复发。

USPTO Abstract

本发明涉及噻吗洛尔或其盐在制备预防和/或治疗丛状血管瘤的药物中的用途。本发明的噻吗洛尔或其盐治疗丛状血管瘤采用局部涂覆方式使用，没有任何创伤，使用简单，治疗耐受性良好，治愈率极高，愈后未见复发。

Drugs covered by this patent

Patent Metadata

Patent number
CN111773226A
Jurisdiction
CN
Classification
—
Expires
2020-10-16
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Childrens Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.